Researchers at Ulster University have just published the latest results of a three-year study looking at OCT1002 in combination with hormone therapy in prostate cancer. The …
Read more
Researchers at Ulster University have just published the latest results of a three-year study looking at OCT1002 in combination with hormone therapy in prostate cancer. The …
Read more
Over 400 people from around the world have voted for OncoTherics in the VOOM 2016 challenge! The VOOM 2016 challenge invites small and start-up businesses …
Read more
OncoTherics is delighted to announce the appointment of Dr Thomas Morris as the company’s new Director and Chief Medical Officer. Dr Morris has worked in …
Read more
OncoTherics has signed a collaboration agreement with the University of Cambridge to progress a series of novel preclinical investigations using OCT1002 in Pancreatic Tumour models. …
Read more
OncoTherics has signed a collaboration agreement with cancer researchers at the University Health Network, Toronto. The investigations will augment OncoTherics formal preclinical studies, providing useful …
Read more
Prime Minister, David Cameron took some time out to visit the Start Up Hub early one morning at the Conservative Party Conference. The photograph shows …
Read more
OncoTherics Director, Professor Stephanie McKeown has been awarded the 2013 Weiss Medal! Weiss Medallists are nominated by the Chairman of the Association for Radiation Research, …
Read more
The Chancellor George Osborne paid a visit to the OncoTherics exhibition stand at the Conservative conference Start-up hub this week. The Chancellor was able to …
Read more
As part of the Start-up hub competition at the 2013 Conservative Party conference, competing start-up companies were asked to make a short “elevator pitch” that would be …
Read more
OncoTherics has won the title “Best Start-Up Company” at the 2013 Conservative Party Conference. The company was voted the winner by hundreds of delegates at …
Read more
OncoTherics is currently raising first round funding. If you are interested in taking part, please provide your contact details so that we can include you on our contact list.
Are you working on a project where OncoTherics' technology might be of help or would you like to collaborate in our research? Please provide your contact details so that we can include you on our contact list.